Tirzepatide-induced ketoacidosis with hyperglycemia in a patient without diabetes

Abstract Tirzepatide,a dual GLP-1 and GIP receptor agonist, is increasingly used for weight management in both patients with diabetes and patients without diabetes. While gastrointestinal side effects such as nausea are common, severe metabolic complications like ketoacidosis are rare and often over...

全面介紹

書目詳細資料

Principais autores:	Mendel Shloush, Vania Rodriguez, Victor Guillen, Diego Lugo Baruqui
格式:	Artigo
語言:	Inglês
出版:	Sociedade Brasileira de Endocrinologia e Metabologia 2026-05-01
叢編:	Archives of Endocrinology and Metabolism
主題:	Tirzepatide ketoacidosis GLP-1 agonist GIP obesity pharmacotherapy weight loss adverse drug reaction
在線閱讀:	http://www.scielo.br/pdf/aem/v70n3/2359-4292-aem-70-03-e260028.pdf
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!